Dergiler / Eastern Journal of Medicine / 2020 / Cilt: 25 - Sayı: 2

Radiotherapy In A Patient With Rectal Cancer and Pelvic Kidney: A Dosimetric Study

Sayfa
241–249
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In patients with locally advanced rectal cancer and pelvic kidney, oncologic treatment (either radiotherapy first or surgery first) should be decided based on the available radiotherapy technique, lymph node status of rectal cancer, and tumor localization.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Pelvic kidney is an important treatment challenge in pelvic malignancies.
📊
Temel Bulgular & Veri:In a patient with rectal cancer and pelvic kidney, where the external iliac lymph nodes were not included in the radiation field, it was determined that, regardless of rectal tumor localization, optimal ≤45 Gy radiotherapy planning could only be performed with the volumetric-modulated arc therapy technique.
💡
Sonuç & Katkı:In patients with locally advanced rectal cancer and pelvic kidney, oncologic treatment (either radiotherapy first or surgery first) should be decided based on the available radiotherapy technique, lymph node status of rectal cancer, and tumor localization.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Pelvic kidney is an important treatment challenge in pelvic malignancies. This study investigated the most appropriate treatment in the presence of simultaneous pelvic kidney in patients with rectal cancer. This study used computed tomography images of postoperative radiotherapy planning in a male patient with rectal cancer. Coplanar intensity-modulated, non-coplanar intensity-modulated, and volumetric-modulated arc radiotherapy rectal cancer planning was performed with six different scenarios based on tumor location and lymph node status; a dosimetric comparison was then performed. In a patient with rectal cancer and pelvic kidney, where the external iliac lymph nodes were not included in the radiation field, it was determined that, regardless of rectal tumor localization, optimal ≤45 Gy radiotherapy planning could only be performed with the volumetric-modulated arc therapy technique. In the same scenario, optimal ≤50.4 Gy radiotherapy planning could only be performed in a distally localized rectal tumor and with the volumetric-modulated arc therapy technique. In contrast, when the external iliac lymph nodes were included in the radiation field for the same patient, regardless of rectal tumor localization, no radiotherapy technique ≤45 Gy could protect the pelvic kidney. In patients with locally advanced rectal cancer and pelvic kidney, oncologic treatment (either radiotherapy first or surgery first) should be decided based on the available radiotherapy technique, lymph node status of rectal cancer, and tumor localization.

🔖

Bu Makaleye Atıf Yap

SERSASLAN, A., DAŞTAN, Y., OKUMUS, N. O., GURSEL, S. B., MEYDAN, A. D. (2020). Radiotherapy In A Patient With Rectal Cancer and Pelvic Kidney: A Dosimetric Study. Eastern Journal of Medicine, Cilt: 25 - Sayı: 2, 241–249. https://ajindex.com/articles/156657

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (7)

  1. Thomas PR, Lindblad AS. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience. Radiother Oncol 1988; 13: 245-252.
  2. Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005; 23: 5644-5650. van Gijn W, Marijnen CA, Nagtegaal ID, et al. Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011; 12: 575-582.
  3. Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 2012; 30: 1926-1933.
  4. Minsky BD, Rödel CM, Valentini V. Clinical Radiation Oncology, 4th ed. Rectal Cancer. Edited by Gunderson LL and Tepper JE. Elsevier, Philadelphia 2016; 992-1018. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, Rectal Cancer, Version 2.2019. Web site: https://www.nccn.org/professionals/ physician_gls/pdf/ rectal.pdf Patel SA, Wo JY, Hong TS. Advancing Techniques of Radiation Therapy for Rectal Cancer. Semin Radiat Oncol 2016; 26: 220-225.
  5. Hong TS, Moughan J, Garofalo MC, et al. NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys 2015; 93: 29-36.
  6. Arbea L, Ramos LI, Martínez-Monge R, Moreno M, Aristu J. Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications. Radiat Oncol 2010; 5: 17. Adamakis I, Pournaras C, Katafigiotis I, et al. Radical cystectomy and lymphadenectomy to two patients with pelvic kidney: surgical pitfalls and considerations. Case Rep Med 2013; 2013: 841806. Myerson RJ, Garofalo MC, El Naqa I, et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.Int J Radiat Oncol Biol Phys 2009; 74: 824-830.
  7. Gay HA, Barthold HJ, O'Meara E, et al.Pelvic normal